Wejovi

Emirates Pharmaceutical Company adopts oral “Wejovi” to reduce weight and reduce heart risks

The Emirates Medicines Corporation announced the approval of Novo Nordisk’s drug “Wejovi” (semaglutide) as a once-daily oral treatment for long-term…

Read More »